Elizabeth Garner
CIK 1608578 · Sr. VP & Chief Medical Officer · last filed 2026-05-11
Elizabeth Garner is a Sr. VP & Chief Medical Officer who has filed 16 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for KZR, was dated May 11, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
16
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Kezar Life Sciences, Inc. (KZR) Delisted | Director | — | $7.29 | — | $0 | 9 | 2026-05-11 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Sr. VP & Chief Medical Officer | 30,300 | $1.51 | $45.8K | $0 | 7 | 2019-01-31 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | Kezar Life Sciences, Inc. (KZR) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-23 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-26 | Kezar Life Sciences, Inc. (KZR) Delisted | Mixed | — | $0 | EDGAR |
| 2023-06-16 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-30 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-26 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-19 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-31 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | — | $0 | EDGAR |